You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

The FDA approved Nemluvio for use in patients with moderate to severe atopic dermatitis in December, following an initial approval in prurigo nodularis in August. Galderma is now facing off ...

A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on digital privacy differs widely among US users. With the HLTH 2022 event now well ...

Dermatology specialist Galderma has FDA approval for prurigo nodularis treatment Nemluvio, one of two new drugs that it thinks will deliver blockbuster sales. Dupixent nears EU approval for rare ...